好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Incidence of Zoster-Associated Limb Paresis (ZALP): A Population-Based Analysis from 2008-2016
Neuromuscular and Clinical Neurophysiology (EMG)
P1 - Poster Session 1 (9:00 AM-5:00 PM)
395
To use population-based tools to determine the epidemiological characteristics of zoster-associated limb paresis (ZALP).
ZALP is a recognized complication of herpes zoster (HZ), with considerable associated morbidity. The incidence of ZALP is unknown.
Utilizing a diagnostic code search of the Rochester Epidemiology Project (REP) database, records for all patients in Olmsted County, MN, USA diagnosed with HZ between 2006-2018 were identified. ZALP cases were adjudicated based on individual chart review. Descriptive and summary statics were applied to the epidemiologic data. Incidence rates were age-adjusted and applied to 2010 census data, with projected growth for subsequent years in the study period.
A total of 7136 HZ patients were identified, 27 (0.4%) of whom developed ZALP (11 upper limb, 16 lower limb). Adjusted total ZALP incidence was 1.37 cases/100,000 persons/year, increasing with age to 11.16 cases/100,000 persons/year in patients 80 years of age and older. Overall incidence was unchanged over the study period. ZALP was more common in men (17/27, p=0.007, OR 3.03 [1.36-6.73]). A majority (78%) of ZALP patients developed post-herpetic neuralgia (PHN).
ZALP is an uncommon complication of HZ which, like HZ, has a much higher incidence in patients over 80 years of age. Unlike HZ, ZALP is more common in men. ZALP patients are significantly more likely to develop PHN than HZ patients.
Authors/Disclosures
James D. Triplett, MBBS (Concord Hospital)
PRESENTER 		Dr. Triplett has nothing to disclose.
Michel Toledano, MD (Mayo Clinic) Dr. Toledano has nothing to disclose.
Lyell K. Jones, MD, FAAN (Mayo Clinic) Dr. Jones has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. Dr. Jones has received publishing royalties from a publication relating to health care. Dr. Jones has received personal compensation in the range of $10,000-$49,999 for serving as a President-Elect with 好色先生. Dr. Jones has a non-compensated relationship as a member of the AAN Board of Directors with AAN that is relevant to AAN interests or activities. Dr. Jones has a non-compensated relationship as a Chair of the Mayo Clinic ACO Board of Directors with Mayo Clinic that is relevant to AAN interests or activities.